TOMORROW -- Register NOW for a live and virtual CME/CE course: An Update on Multiple Sclerosis Patient Care for Advanced Practice Providers scheduled for tomorrow May 27th from 4 pm - 6 pm MST, just before #CMSC 2025. Join Amy Perrin Ross, APN, MSN, CNRN, MSCN and esteemed

1) A new #accredited #tweetorial! 📌The Importance to Cardiorenal Outcomes of Effective Blood Pressure Control & the Pathophysiologic Role of Aldosterone Dysregulation. Our returning expert faculty is Sophia Ambruso DO @Sophia_Kidney, nephrologist & podcaster @freelyfiltered

1) A new #accredited #tweetorial! 📌The Importance to Cardiorenal Outcomes of Effective Blood Pressure Control & the Pathophysiologic Role of Aldosterone Dysregulation. Our returning expert faculty is Sophia Ambruso DO @Sophia_Kidney, nephrologist & podcaster @freelyfiltered

1) Welcome back to @cardiomet_ce, your ONLY source for 🆓, expert-authored CE/#CME by expert authors like our newest faculty member Mazen Hanna MD Mazen Hanna, #cardiologist at Cleveland Clinic where he is Co-Director of the #Amyloidosis Center my.clevelandclinic.org/departments/ca…

5) A noninvasive definitive diagnostic method for #ATTR#CM involves: a. Serum urine and protein #electrophoresis (#SPEP & #UPEP) b. #Endomyocardial biopsy with Congo red staining c. Bone-avid radiotracer #scintigraphy d. Genetic testing for #TTR mutations alone

6) Which of the following is an approved “silencer” treatment for #ATTR_CM? a. #tafamadis b. #acoramidis c. #vutrisiran d. #CRISPR-Cas9 gene editing

Presented at #ERA25: In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results:

Original Article: Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis (ESSENCE) nej.md/3EVFAFM Editorial: Semaglutide for Metabolic Dysfunction–Associated Steatohepatitis nej.md/3ZJSmOQ #Endocrinology #Gastroenterology

1) Welcome to a new #accredited #tweetorial from @cardiomet_ce! This tweetorial is the first of 3⃣ that will address advances in the secondary prevention of ischemic, non-cardioembolic #stroke #SSP. Follow this 🧵for 0.5hr 🆓 CE/#CME !

26) But right now, you can claim your 0.5hr of 🆓CE/#CME but pointing your 🖱️ to cardiometabolic-ce.com/antithrombotic…. Many thanks to our expert author Ashkan Shoamanesh !

Preventing chronic kidney disease and maintaining kidney health: conclusions from KDIGO Controversies Conference ca. 2025 #Nephpearls 👉🏼 pubmed.ncbi.nlm.nih.gov/40536455/

In a new article on measles, the authors review the epidemiology, clinical presentation, and associated illnesses as well as treatment and prevention strategies. Read the Review Article “Measles 2025” by Lien Anh Ha Do, MD, PhD, and Kim Mulholland, MB, BS, MD, from

Today, NEJM reports that Efruxifermin (an FGF21 agonist) is the first drug to reduce fibrosis in compensated cirrhosis due to NASH. This effect is seen after 96 weeks, so patience is key. Could combining Semaglutide make it even more powerful?

How much do beta blockers help after a heart attack — even when the heart’s pumping well? We revisit the origins of beta blockers in post-MI care, examine how evidence evolved, and explore the REDUCE-AMI trial, which questions whether beta blockers are still needed for all. 🎧

Academic CME: Nephrology #Nephpearls 👉 academiccme.com/faculty/edgar-…

Meta-analysis of GLP-1RAs and gastrointestinal adverse events. GLP-1RAs are associated with an increased risk of cholelithiasis and GERD, but do not appear to increase the risk of other gastrointestinal or biliary adverse events. gastrojournal.org/article/S0016-…

16 most frequently asked ECG patterns Save it. Share it

59% of patients with type 2 diabetes in primary care clinics have MASLD, 7% have advanced fibrosis (transient elastography ≥ 10 kPa), and 1.9% have cirrhosis. onlinelibrary.wiley.com/doi/10.1111/jo…

🔴 2025 JCS/JHFS Guideline on Diagnosis and Treatment of Heart Failure⤵️ *New* 🔹onlinejcf.com/article/S1071-… #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd

The latest 2025 #Hypertension Guidelines are out 📣 #Nephpearls 📌 Use of risk-based thresholds for initiation of BP treatment 📌 BP thresholds and recommendations for treatment and follow-up 📌 Screening for features suggesting secondary hypertension 👉🏼